#SolanaAnzaUnveilsAgave4.3ReleasePlan
$MU Perp $SNXX Perp
With a view to Develop & Genetically modify molecule sacubitril in the treatment of Cardiovascular disease ----- Swiss drug maker Novartis has gained the right to invalidate the patent of the molecule sacubitril & valsartan with Intas Pharmaceuticals & Accord Healthcare.
Meanwhile Chinas Pony.AI & Uber has gained an order of 200 Robotaxis order in Europe. The two firm also wants to penetrate middle east market.
Dollar Index ---- Upward ---- Inflows Expected ---- Divergence of Slope Expected
$MU Perp $SNXX Perp
With a view to Develop & Genetically modify molecule sacubitril in the treatment of Cardiovascular disease ----- Swiss drug maker Novartis has gained the right to invalidate the patent of the molecule sacubitril & valsartan with Intas Pharmaceuticals & Accord Healthcare.
Meanwhile Chinas Pony.AI & Uber has gained an order of 200 Robotaxis order in Europe. The two firm also wants to penetrate middle east market.
Dollar Index ---- Upward ---- Inflows Expected ---- Divergence of Slope Expected